Zosano Pharma
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Zosano Pharma's past years’ income statements indicate that its last revenue has increased compared to the previous period by 250% to $785,000. The net income raised on -$30,114,000 and profit margin reached -3836%. Total operating expenses were $31,521,000.
Profit Margin
| 2012 | 11.62M | 1.81M | 15.64% |
|---|---|---|---|
| 2013 | 4.25M | -5.60M | -131.95% |
| 2014 | 2.86M | -14.24M | -497.76% |
| 2015 | 313K | -28.42M | -9082.11% |
| 2016 | 0 | -29.83M | |
| 2017 | 0 | -29.10M | |
| 2018 | 0 | -35.35M | |
| 2019 | 0 | -37.58M | |
| 2020 | 224K | -33.36M | -14896.87% |
| 2021 | 785K | -30.11M | -3836.18% |
ZSAN Income Statement (2012 – 2021)
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 785K | 224K | 0 | 0 | 0 | 0 | 313K | 2.86M | 4.25M | 11.62M |
Cost of revenue | 796K | 171K | 0 | 0 | 0 | 0 | 0 | 100K | 0 | 0 |
Gross profit | -11K | 53K | 0 | 0 | 0 | 0 | 313K | 2.76M | 4.25M | 11.62M |
Operating exp. | ||||||||||
Research and development | 20.97M | 21.62M | 25.38M | 25.50M | 20.18M | 20.45M | 20.36M | 10.95M | 7.63M | 5.39M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 31.52M | 32.81M | 37.19M | 34.86M | 28.37M | 28.63M | 26.68M | 15.37M | 12.21M | 8.47M |
Operating income | -29.73M | -32.75M | -37.19M | -35.37M | -28.37M | -28.63M | -26.36M | -12.61M | -7.96M | 3.14M |
Other income (expenses), net | -189K | -611K | -392K | 18K | -735K | -1.19M | -2.05M | -1.62M | 2.36M | -1.33M |
Income before tax | -29.92M | -33.36M | -37.58M | -35.35M | -29.10M | -29.83M | -28.42M | -14.24M | -5.60M | 1.81M |
Income tax expense | 189K | 108K | 131K | 397K | 7K | -1.19M | -260K | -1.62M | 2.36M | 0 |
Net income | -30.11M | -33.36M | -37.58M | -35.35M | -29.10M | -29.83M | -28.42M | -14.24M | -5.60M | 1.81M |
Earnings per share | ||||||||||
Basic EPS | -0.27 | -0.49 | -2.29 | -3.74 | -16.82 | -43.32 | -49.81 | -24.52 | -21.52 | 6.97 |
Diluted EPS | -0.27 | -0.49 | -2.29 | -3.74 | -16.82 | -43.32 | -49.81 | -24.52 | -21.52 | 6.97 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source |